{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:06:06Z","timestamp":1786118766311,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1097\/wnf.0b013e31806ad6cb","type":"journal-article","created":{"date-parts":[[2008,3,25]],"date-time":"2008-03-25T03:01:05Z","timestamp":1206414065000},"page":"93-96","source":"Crossref","is-referenced-by-count":19,"title":["Cutaneous Drug Eruptions by Current Antiepileptics"],"prefix":"10.1097","volume":"31","author":[{"given":"Sevki","family":"Sahin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuman","family":"Comert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozlem","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunay","family":"Ayalp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel","family":"Karsidag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210203","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1212\/01.WNL.0000156354.20227.F0","article-title":"Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics.","volume":"64","author":"Mockenhaupt","year":"2005","journal-title":"Neurology"},{"key":"R2-5-20210203","first-page":"42","article-title":"A case of cutaneous leukocytoclastic vasculitis associated with gabapentin.","volume":"44","author":"Poon","year":"2003","journal-title":"Singapore Med J"},{"key":"R3-5-20210203","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0733-8635(05)70106-6","article-title":"Recent advances in the pathology of cutaneous drug eruptions.","volume":"17","author":"Crowson","year":"1999","journal-title":"Dermatol Clin"},{"issue":"6","key":"R4-5-20210203","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2165\/00128071-200304060-00005","article-title":"Progress in the understanding of the pathology and pathogenesis of cutaneous drug eruptions.","volume":"4","author":"Crowson","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"R6-5-20210203","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1365-4362.2003.01831.x","article-title":"The role of gabapentin in treating diseases with cutaneous manifestations and pain.","volume":"42","author":"Scheinfeld","year":"2003","journal-title":"Int J Dermatol"},{"key":"R7-5-20210203","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1111\/j.1528-1157.1999.tb00933.x","article-title":"Postherpetic neuralgia: role of gabapentin and other treatment modalities.","volume":"6","author":"Beydoun","year":"1999","journal-title":"Epilepsia"},{"key":"R8-5-20210203","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005792-198209000-00003","article-title":"Population-based study of herpes zoster and its sequelae.","volume":"61","author":"Ragozzino","year":"1982","journal-title":"Medicine"},{"key":"R9-5-20210203","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1533-2500.2005.00035.x","article-title":"Postherpetic neuralgia: the never-ending challenge.","volume":"5","author":"Niv","year":"2005","journal-title":"Pain Pract"},{"key":"R10-5-20210203","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/bmj.298.6671.431","article-title":"Lack of effect of acyclovir on post herpetic neuralgia.","volume":"298","author":"McKendrick","year":"1989","journal-title":"BMJ"},{"key":"R11-5-20210203","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.wnf.0000172497.24770.b0","article-title":"Botulinum toxin and intractable trigeminal neuralgia.","volume":"28","author":"Turk","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"R12-5-20210203","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0190-9622(89)70176-6","article-title":"Usefulness of case report literature in determining drugs responsible for toxic epidermal necrolysis.","volume":"21","author":"Stern","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"R13-5-20210203","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"R14-5-20210203","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs.","volume":"19","author":"Roujeau","year":"1994","journal-title":"N Eng J Med"},{"key":"R15-5-20210203","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00002018-199818040-00004","article-title":"Safety review of adult clinical trial experience with lamotrigine.","volume":"18","author":"Messenheimer","year":"1998","journal-title":"Drug Saf"},{"issue":"2","key":"R16-5-20210203","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/01.wnf.0000159956.87511.67","article-title":"Meta-analysis and indirect comparisons of levetiracetam with other second-generation antiepileptic drugs in partial epilepsy.","volume":"28","author":"Otoul","year":"2005","journal-title":"Clin Neuropharmacol"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002826-200803000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:55:28Z","timestamp":1786035328000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-200803000-00005"}},"subtitle":["Case Reports and Alternative Treatment Options"],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e31806ad6cb","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}